Oxaliplatin – Eloxatin® – Elplat® - Debiopharm

Home » Media » Press Releases

Oxaliplatin – Eloxatin® – Elplat®

Date	Article Title
21 Mar 2005	Debiopharm announces import approval from Elplat® (Oxaliplatin) in Japan
07 Feb 2005	Debiopharm S.A. announces marketing approval for a new formulation of Eloxatin® (Oxaliplatin for injection)
03 Jun 2004	Debiopharm´s Eloxatin® (Oxaliplatin) awarded Prix Galien in France for innovative cancer therapy
03 Jun 2004	L´Eloxatine® (Oxaliplatine) de Debiopharm reçoit le Prix Galien en France pour thérapie innovante contre le cancer
04 Mar 2004	Yakult Honsha files Initial Submission for Marketing Authorisation of Debiopharm´s Oxaliplatin in Japan
19 Jan 2004	ELOXATIN™ submitted in the United States and in Europe for the adjuvant treatment of patients with colon cancer
11 Jan 2004	Eloxatin™ (oxaliplatin for injection) approved in the United States for the 1st line treatment of metastatic colorectal cancer
07 Jan 2004	ELOXATIN® is becoming a cornerstone therapy for the treatment of metastatic colorectal cancer in Europe
27 Aug 2002	Debiopharm extends its collaboration with Sanofi-Synthélabo on Eloxatin®
19 Aug 2002	Media Alert: successful registration after shortest ever review by the FDA of Eloxatin

Latest News

09 November 2011 Augurix Diagnostics receives the 2011 ‘Debiopharm /Valais Award’ For its point-of-care diagnostic test for the early detection of Celiac disease

05 October 2011 The Japanese Cancer Association and Debiopharm Group™ present Doctors Arakawa and Kurokawa with the 2011 ‘JCA-Mauvernay Award’for their innovative and outstanding research in the field of cancer

08 September 2011 Debiopharm Group™ presents the ‘Debiopharm Group™ Life Sciences Award 2011’ and two ‘Junior Debiopharm Group™ Awards 2011’ at the ISREC 2011 Life Sciences Symposium

Debiopharm on

© 2012 Debiopharm Group